date:Sep 13, 2012
Scientists studying pectins that inhibit a protein called galectin-3 - elevated levels of which are associated with a higher risk of heart failure - say their work could create a completely new category of cardiovascular health foods and supplements.
Pectacea, a start-up company emerging from Wageningen University and University Medical Centre Groningen in the Netherlands, is setting up a small office in Massachusetts, and sees the US as its primary target, chairman Dr Pieter Muntendam told Foo